Search

everythinglearnresearchcommunity

for

Search:↓

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Androgenetic alopecia is significantly linked to metabolic syndrome.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Herbal formula shows promise for hair loss treatment.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Hair loss in men treated best with early medication or transplant, new treatments researched.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Finasteride may not affect gynecomastia recurrence after mastectomy.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Finasteride may cause slight depression and anxiety.

As of 1994, treatments for liver cancer had not significantly improved patient survival.